Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

15.25
Delayed Data
As of May 24
 +0.55 / +3.74%
Today’s Change
9.66
Today|||52-Week Range
19.90
+1.33%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close14.70
Today’s open14.85
Day’s range14.80 - 15.33
Volume903,599
Average volume (3 months)809,689
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)+76.52%
Earnings growth (this year)-365.97%
Earnings growth (next 5 years)--
Revenue growth (last year)+22.27%
P/E ratioNM
Price/Sales9.43
Price/Book2.81

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-1.45-6.64%
XLRNAcceleron Pharma Inc+0.75+2.95%
EPZMEpizyme Inc-0.20-1.20%
FPRXFive Prime Therapeut...+0.67+2.25%
Data as of 3:59pm ET, 05/24/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$109.6M
Annual profit (last year)-$21.0M
Net profit margin-19.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer &
Senior Vice President
Scott M. Storer
Corporate headquarters
Cambridge, Massachusetts

Forecasts